ekonominyheter

TranslateRSSMobil
Why Bristol-Myers Squibb Co. Leaped 15% Higher in October

Why Bristol-Myers Squibb Co. Leaped 15% Higher in October

Fool.com 5/11 10:46

Bristol-Myers Squibb was among the best performing pharmaceutical stocks in October, launching 15% higher and tacking on more than $12 billion in market value. Find out what sent Bristol-Myers' shares soaring higher and whether or not it'll continue.

Till artikeln

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status